<DOC>
	<DOCNO>NCT02388750</DOCNO>
	<brief_summary>This phase II study investigate use palonosetron efficacy prophylaxis rescue single multiple fraction radiation induce nausea vomiting . This prospective study employ parallel arm design , allow inclusion patient pre-existing nausea vomit versus current nausea vomiting . Eligible patient receive radiotherapy know low moderate emetogenic risk receive every day dose 0.5 mg palonosetron length treatment . Nausea , vomit , use rescue medication , impact quality life monitor radiation treatment completion .</brief_summary>
	<brief_title>Prospective Study Palonosetron Radiation Induced Nausea Vomiting ( RINV )</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Palonosetron</mesh_term>
	<criteria>Informed consent Patient receive radiation therapy consider moderate risk ( upper abdomen , upper half body irradiation ) low risk ( low thorax pelvis ) emetogenic palliative radiotherapy . Patients group accord nausea vomit status baseline follow : Group 1 : Patient experience nausea vomit baseline Group 2 : Patient experience least mild nausea and/or least mild vomit baseline Patient schedule receive cranial radiation therapy within 10 day follow completion protocol RT . Patient receive cranial RT within 7 day prior commencement protocol RT . Patient schedule receive chemotherapy within 10 day follow completion protocol RT . Patient receive moderately highly emetogenic chemotherapy within 7 day prior commencement protocol RT . Patient schedule change regimen/dose start use low dose corticosteroid ( inhaled topical permit ) , medication consider antiemetic property within 48 hour prior protocol RT . Patient schedule change regimen/dose start use low dose corticosteroid ( inhaled topical permit ) , medication consider antiemetic property within 10 day follow completion protocol RT . Concurrent use corticosteroid protocol RT permit , unless low dose corticosteroid ( hydrocortisone ) use cancer treatment Patient allergic protocol medication . Patient Karnofsky Performance Status score &lt; 40 . Patient woman pregnant childbearing potential use contraceptive measure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>nausea</keyword>
	<keyword>vomit</keyword>
	<keyword>radiation</keyword>
	<keyword>anti-emetic drug</keyword>
</DOC>